Scrip
US FDA endocrine/metabolic panel to review two orphan drugs in January
24 November 2009
Sue Sutter
Please Login to read the full article.
24 November 2009
Sue Sutter
The US FDA's endocrinologic and metabolic drugs panel will convene on January 12th to discuss Actelion's NDA for Zavesca (miglustat) for the treatment of progressive neurological manifestations in patients with Niemann-Pick type C (NP-C) disease.
On January 13th, the panel will consider...
Please Login to read the full article.
RELATED CONTENT
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
